Suppr超能文献

新型高分辨率泪膜成像仪评估人工泪液对泪膜短期影响的初步研究。

The Short-term Effects of Artificial Tears on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager: A Pilot Study.

机构信息

Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY.

Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY.

出版信息

Cornea. 2024 Oct 1;43(10):1264-1271. doi: 10.1097/ICO.0000000000003505. Epub 2024 Feb 28.

Abstract

PURPOSE

The purpose of this study was to investigate the effects of artificial tears (AT) on the sublayers of the tear film assessed by a novel tear film imaging (TFI) device.

METHODS

The mucoaqueous layer thickness (MALT) and lipid layer thickness (LLT) of 198 images from 11 healthy participants, 9 of whom had meibomian gland disease, were prospectively measured before and after exposure to 3 different AT preparations (Refresh Plus; Retaine [RTA]; Systane Complete PF [SYS]), using a novel nanometer resolution TFI device (AdOM, Israel). Participants were assessed at baseline and at 1, 5, 10, 30, and 60 minutes after instilling 1 drop of AT during 3 sessions on separate days. Repeated-measures analysis of variances were used for comparisons with P < 0.05 considered significant.

RESULTS

For all ATs, the mean MALT was greatest 1 minute after drop instillation, with an increase of 67%, 55%, and 11% above the baseline for SYS, Refresh Plus, and RTA, respectively. The SYS formulation demonstrated the highest percentage increases in mean MALT and LLT at most postdrop time points. The MALT differences were significantly higher in the SYS than in the RTA ( P = 0.014). After 60 minutes, no AT group demonstrated statistically significant changes in MALT or LLT compared with baseline.

CONCLUSIONS

We report, for the first time, the effects of AT on MALT and LLT using a high-resolution TFI. A substantial acute mean MALT increase occurs 1 minute after AT instillation with all agents tested, but there were clear differences in response and durability, suggesting the benefits of choosing specific AT according to the needs of each patient.

摘要

目的

本研究旨在通过一种新型泪膜成像(TFI)设备评估人工泪液(AT)对泪膜各层的影响。

方法

前瞻性测量了 11 名健康参与者(其中 9 名患有睑板腺疾病)的 198 张图像的黏液层厚度(MALT)和脂质层厚度(LLT),这些图像是在使用新型纳米分辨率 TFI 设备(AdOM,以色列)滴入 3 种不同 AT 制剂(Refresh Plus;Retaine [RTA];Systane Complete PF [SYS])前后获得的。在 3 天的 3 次滴注中,分别在基线以及滴注后 1、5、10、30 和 60 分钟对参与者进行评估。采用重复测量方差分析进行比较,P < 0.05 认为有统计学意义。

结果

对于所有 AT,滴注后 1 分钟时的平均 MALT 最大,与基线相比,SYS、Refresh Plus 和 RTA 的平均 MALT 分别增加了 67%、55%和 11%。在大多数滴注后时间点,SYS 制剂显示出最高的平均 MALT 和 LLT 百分比增加。SYS 组的 MALT 差异明显高于 RTA 组(P = 0.014)。60 分钟后,与基线相比,没有 AT 组的 MALT 或 LLT 发生统计学上的显著变化。

结论

我们首次使用高分辨率 TFI 报告了 AT 对 MALT 和 LLT 的影响。在所有测试的药物中,滴注后 1 分钟时均会出现明显的平均 MALT 急性增加,但在反应和持续时间方面存在明显差异,这表明根据每位患者的需求选择特定的 AT 具有明显的优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验